Meet BacVax: a PBC startup working on a vaccine to prevent ear infections in young children.
Dr. Terrence Stull’s company, called BacVax, is developing a vaccine to prevent ear infections in young children.
BacVax is a University of Arizona spinoff founded by Stull, former senior vice president of research at Phoenix Children’s Hospital.
BacVax uses molecular genetics to study Haemophilus influenzae, a common cause of ear infections. Stull moved his startup from the University of Arizona College of Medicine – Phoenix to 850 PBC on the Phoenix Bioscience Core in July 2021, noting the building is a prime location to grow and expand.
Related reading:
Check out the new Connect Labs at 850 PBC, opening in just a few short weeks.
Check out the video below and read more about BacVax here on the Arizona PBS website as part of its Health Tomorrow segment, supported by the Phoenix Bioscience Core.
More news from the PBC
- City of Hope appoints Aleksandar Sekulic to key cancer genomics role at TGen
- Arizona BioIndustry Association opens office on Phoenix Bioscience Core at Connect Labs
- Arizona Board of Regents approves Arizona State University’s new medical school
- University of Arizona College of Medicine – Phoenix receives $3 million NIH grant for lung disease in infants
- Phoenix Bioscience Core seeks new workforce development coordinator to reduce Arizona’s health care workforce
- Recap: 2023 State of the Phoenix Bioscience Core
- City of Phoenix votes to update development plan for Phoenix Bioscience Core